Anaveon
PrivateLast Round
Series B
Dec 16, 2021
Est. Valuation
$207M
Total Funding Raised
$156.67M
Momentum Score
25 /100
Company Overview
Anaveon is a biopharmaceutical company that develops next-generation IL-2-based therapeutic antibodies aimed at enhancing the immune system to provide significant benefits for cancer patients and treat diseases related to immune system dysfunction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anaveon Comps
Public and private peers based on sector, stage, and business model.
Anaveon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 16, 2021 | ||||
| Series A | Feb 26, 2019 | ||||
| Grant | Dec 1, 2017 |
Anaveon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Forbion Capital Partners | Series B |
| Syncona | Series B, Series A |
| Pontifax Credit | Series B |
| TD Securities | Series B |
| UZH Life Sciences Fund | Series A |
| Novartis Venture Fund | Series A, Series B |
| Pfizer Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Thaminda Ramanayake appointed as new Chief Executive Officer.
Anaveon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Anaveon's valuation, stock price, and market status.
